<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1286" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1286/" /><meta name="ncbi_pagename" content="Carney Complex - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Carney Complex - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Carney Complex" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/08/16" /><meta name="citation_author" content="Constantine A Stratakis" /><meta name="citation_author" content="Margarita Raygada" /><meta name="citation_pmid" content="20301463" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1286/" /><meta name="citation_keywords" content="Carney Syndrome" /><meta name="citation_keywords" content="Carney Syndrome" /><meta name="citation_keywords" content="cAMP-dependent protein kinase type I-alpha regulatory subunit" /><meta name="citation_keywords" content="PRKAR1A" /><meta name="citation_keywords" content="Carney Complex" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Carney Complex" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Constantine A Stratakis" /><meta name="DC.Contributor" content="Margarita Raygada" /><meta name="DC.Date" content="2018/08/16" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1286/" /><meta name="description" content="Carney complex (CNC) is characterized by skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas. Pale brown to black lentigines are the most common presenting feature of CNC and typically increase in number at puberty. Cardiac myxomas occur at a young age, may occur in any or all cardiac chambers, and can manifest as intracardiac obstruction of blood flow, embolic phenomenon, and/or heart failure. Other sites for myxomas include the skin, breast, oropharynx, and female genital tract. Primary pigmented nodular adrenocortical disease (PPNAD), which causes Cushing syndrome, is the most frequently observed endocrine tumor in CNC, occurring in approximately 25% of affected individuals. Large-cell calcifying Sertoli cell tumors (LCCSCTs) are observed in one third of affected males within the first decade and in most adult males. Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Clinically evident acromegaly from a growth hormone (GH)-producing adenoma is evident in approximately 10% of adults. Psammomatous melanotic schwannoma (PMS), a rare tumor of the nerve sheath, occurs in an estimated 10% of affected individuals. The median age of diagnosis is 20 years." /><meta name="og:title" content="Carney Complex" /><meta name="og:type" content="book" /><meta name="og:description" content="Carney complex (CNC) is characterized by skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas. Pale brown to black lentigines are the most common presenting feature of CNC and typically increase in number at puberty. Cardiac myxomas occur at a young age, may occur in any or all cardiac chambers, and can manifest as intracardiac obstruction of blood flow, embolic phenomenon, and/or heart failure. Other sites for myxomas include the skin, breast, oropharynx, and female genital tract. Primary pigmented nodular adrenocortical disease (PPNAD), which causes Cushing syndrome, is the most frequently observed endocrine tumor in CNC, occurring in approximately 25% of affected individuals. Large-cell calcifying Sertoli cell tumors (LCCSCTs) are observed in one third of affected males within the first decade and in most adult males. Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Clinically evident acromegaly from a growth hormone (GH)-producing adenoma is evident in approximately 10% of adults. Psammomatous melanotic schwannoma (PMS), a rare tumor of the nerve sheath, occurs in an estimated 10% of affected individuals. The median age of diagnosis is 20 years." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1286/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/carney/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1286/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8AD524E040D10100000000054B020D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1286_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1286_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cfc/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cpt1a/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1286_"><span class="title" itemprop="name">Carney Complex</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Carney Syndrome</div><p class="contrib-group"><span itemprop="author">Constantine A Stratakis</span>, MD, DSc and <span itemprop="author">Margarita Raygada</span>, MSc, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1286_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1286_ai__"><div class="contrib half_rhythm"><span itemprop="author">Constantine A Stratakis</span>, MD, DSc<div class="affiliation small">Chief, Section on Endocrinology and Genetics<br />Scientific Director, National Institute of Child Health and Human Development<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@ckatarts" class="oemail">vog.hin.liam@ckatarts</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Margarita Raygada</span>, MSc, PhD<div class="affiliation small">Office of the Clinical Director, National Institute of Child Health and Human Development<br />National Institutes of Health<br />Bethesda, Maryland</div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 5, 2003</span>; Last Update: <span itemprop="dateModified">August 16, 2018</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="carney.Summary" itemprop="description"><h2 id="_carney_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Carney complex (CNC) is characterized by skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas. Pale brown to black lentigines are the most common presenting feature of CNC and typically increase in number at puberty. Cardiac myxomas occur at a young age, may occur in any or all cardiac chambers, and can manifest as intracardiac obstruction of blood flow, embolic phenomenon, and/or heart failure. Other sites for myxomas include the skin, breast, oropharynx, and female genital tract. Primary pigmented nodular adrenocortical disease (PPNAD), which causes Cushing syndrome, is the most frequently observed endocrine tumor in CNC, occurring in approximately 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Large-cell calcifying Sertoli cell tumors (LCCSCTs) are observed in one third of affected males within the first decade and in most adult males. Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Clinically evident acromegaly from a growth hormone (GH)-producing adenoma is evident in approximately 10% of adults. Psammomatous melanotic schwannoma (PMS), a rare tumor of the nerve sheath, occurs in an estimated 10% of affected individuals. The median age of diagnosis is 20 years.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of CNC is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with two or more major diagnostic criteria and/or by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKAR1A</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Open-heart surgery for cardiac myxomas; surgical excision of cutaneous and mammary myxomas; bilateral adrenalectomy for Cushing syndrome; transsphenoidal surgery for pituitary adenoma; surgery for cancerous thyroid adenomas; orchiectomy for boys with aggressive LCCSCT and gynecomastia to avoid premature epiphyseal fusion and induction of central precocious puberty (mild gynecomastia may be treated medically); surgery to remove primary and/or metastatic PMS.</p><p><i>Prevention of primary manifestations:</i> Surgical removal of a cardiac myxoma prior to the development of heart dysfunction, stroke, or other embolism.</p><p><i>Prevention of secondary complications:</i> Medical or surgical treatment of endocrine manifestations may prevent the metabolic abnormalities from Cushing syndrome or arthropathy and complications from acromegaly.</p><p><i>Surveillance:</i></p><ul><li class="half_rhythm"><div>For prepubertal children: echocardiography annually or biannually for those with a history of excised myxoma; testicular ultrasound with close monitoring of linear growth rate and annual pubertal staging.</div></li><li class="half_rhythm"><div>For postpubertal children and adults: echocardiogram annually or biannually for those with a history of excised myxoma; annual testicular ultrasound; baseline thyroid ultrasound with repeat as necessary; baseline transabdominal ultrasound of the ovaries with repeat as necessary; annual urinary free cortisol levels; annual serum IGF-1 levels.</div></li></ul><p>Further evaluation in all age groups may include: diurnal cortisol levels, dexamethasome stimulation test, and adrenal computed tomography for primary pigmented nodular adrenocortical disease; pituitary MRI, 3-hour oral glucose tolerance test, and 90-minute thyroid releasing hormone testing for gigantism/acromegaly; MRI (brain, spine, chest, abdomen, retroperitoneum, pelvis) for psammamotous melanotic schwannoma.</p><p><i>Evaluation of relatives at risk:</i> When the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to clarify the genetic status of at-risk family members so that appropriate evaluation and surveillance can enable early diagnosis of treatable manifestations.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>CNC is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Approximately 70% of individuals diagnosed with CNC have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; approximately 30% have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an individual with CNC has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p></div></div><div id="carney.Diagnosis"><h2 id="_carney_Diagnosis_">Diagnosis</h2><div id="carney.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Carney complex (CNC) <b>should be suspected</b> in individuals with the following features.</p><p><b>Major diagnostic criteria for CNC</b></p><ul><li class="half_rhythm"><div>Spotty skin pigmentation with typical distribution (lips, conjunctiva and inner or outer canthi, vaginal and penile mucosa)</div></li><li class="half_rhythm"><div>Myxoma* (cutaneous and mucosal)</div></li><li class="half_rhythm"><div>Cardiac myxoma*</div></li><li class="half_rhythm"><div>Breast myxomatosis* or fat-suppressed MRI findings suggestive of this diagnosis</div></li><li class="half_rhythm"><div>Primary pigmented nodular adrenocortical disease (PPNAD)* or paradoxic positive response of urinary glucocorticosteroid excretion to dexamethasone administration during Liddle's test</div></li><li class="half_rhythm"><div>Acromegaly as a result of growth hormone (GH)-producing adenoma*</div></li><li class="half_rhythm"><div>Large-cell calcifying Sertoli cell tumor (LCCSCT)* or characteristic calcification on testicular ultrasound</div></li><li class="half_rhythm"><div>Thyroid carcinoma* or multiple, hypoechoic nodules on thyroid ultrasound in a child younger than age 18 years</div></li><li class="half_rhythm"><div>Psammomatous melanotic schwannomas (PMS)*</div></li><li class="half_rhythm"><div>Blue nevus, epithelioid blue nevus*</div></li><li class="half_rhythm"><div>Breast ductal adenoma*</div></li><li class="half_rhythm"><div>Osteochondromyxoma*</div></li></ul><p>Note: * denotes after histologic confirmation [<a class="bk_pop" href="#carney.REF.mateus.2008.801">Mateus et al 2008</a>].</p><p><b>Supplementary criteria</b></p><ul><li class="half_rhythm"><div>Affected <a class="def" href="/books/n/gene/glossary/def-item/first-degree-relative/">first-degree relative</a></div></li><li class="half_rhythm"><div>Inactivating <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKAR1A</i></div></li></ul><p><b>Findings suggestive of or possibly associated with CNC, but not diagnostic for the disease</b></p><ul><li class="half_rhythm"><div>Intense freckling (without darkly pigmented spots or typical distribution)</div></li><li class="half_rhythm"><div>Blue nevus, common type (if multiple)</div></li><li class="half_rhythm"><div>Caf&#x000e9; au lait macules or other "birthmarks"</div></li><li class="half_rhythm"><div>Elevated IGF-I levels, abnormal glucose tolerance test (GTT), or paradoxic GH response to TRH (thyrotropin-releasing hormone) testing in the absence of clinical acromegaly</div></li><li class="half_rhythm"><div>Cardiomyopathy</div></li><li class="half_rhythm"><div>Pilonidal sinus</div></li><li class="half_rhythm"><div>History of Cushing's syndrome, acromegaly, or sudden death in extended family</div></li><li class="half_rhythm"><div>Multiple skin tags or other skin lesions; lipomas</div></li><li class="half_rhythm"><div>Colonic polyps (usually in association with acromegaly)</div></li><li class="half_rhythm"><div>Hyperprolactinemia (usually mild and almost always combined with clinical or subclinical acromegaly)</div></li><li class="half_rhythm"><div>Single, benign thyroid nodule in a child younger than age 18 years; multiple thyroid nodules in an individual older than age 18 years (detected on ultrasound examination)</div></li><li class="half_rhythm"><div>Family history of carcinoma, in particular of the thyroid, colon, pancreas, and ovary; other multiple benign or malignant tumors</div></li></ul><p>&#x02013; Criteria reprinted from <a class="bk_pop" href="#carney.REF.mateus.2008.801">Mateus et al [2008]</a> with permission of Elsevier Publishing</p></div><div id="carney.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of CNC <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with two or more major diagnostic criteria (see <a href="#carney.Suggestive_Findings">Suggestive Findings</a>). Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKAR1A</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1286/table/carney.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcarneyTmoleculargenetictestingused" rid-ob="figobcarneyTmoleculargenetictestingused">Table 1</a>) can confirm the diagnosis in individuals with two or more major diagnostic criteria and establishes the diagnosis if clinical features are inconclusive.</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>PRKAR1A</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>PRKAR1A</i> and other genes of interest (see <a href="#carney.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK1286/table/carney.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcarneyTmoleculargenetictestingused" rid-ob="figobcarneyTmoleculargenetictestingused">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="carney.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Carney Complex</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1286/table/carney.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carney.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKAR1A</i></td><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">60%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~10%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7,&#x000a0;8,&#x000a0;9</sup></td><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">NA</td><td headers="hd_h_carney.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="carney.TF.1.1"><p class="no_margin">See <a href="/books/NBK1286/#carney.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="carney.TF.1.2"><p class="no_margin">See <a href="#carney.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="carney.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="carney.TF.1.4"><p class="no_margin">In the largest study to date, 114 (62%) of 185 families studied had an identifiable <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#carney.REF.bertherat.2009.2085">Bertherat et al 2009</a>]. The variant detection frequency increases to 80% in individuals with CNC presenting with Cushing syndrome caused by PPNAD [<a class="bk_pop" href="#carney.REF.cazabat.2007.1">Cazabat et al 2007</a>].</p></div></dd><dt>5. </dt><dd><div id="carney.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="carney.TF.1.6"><p class="no_margin">In a study of 36 unrelated individuals with CNC who were negative for <i>PRKAR1A</i> single-nucleotide variants, two large <i>PRKAR1A</i> deletions were identified [<a class="bk_pop" href="#carney.REF.horvath.2008.388">Horvath et al 2008</a>]. Of 51 individuals with CNC who were negative for other <i>PRKAR1A</i> pathogenic variants, 21.6% had a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#carney.REF.salpea.2014.e183">Salpea et al 2014</a>] (see <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">Table 2</a>). The deletions ranged from 328 bp to 3 Mb, affecting part or all of <i>PRKAR1A</i>; all deletions led to PRKAR1A <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>.</p></div></dd><dt>7. </dt><dd><div id="carney.TF.1.7"><p class="no_margin">Approximately 20% of families with CNC have been linked to 2p16 [<a class="bk_pop" href="#carney.REF.stratakis.1996.699">Stratakis et al 1996</a>].</p></div></dd><dt>8. </dt><dd><div id="carney.TF.1.8"><p class="no_margin"><i>PRKACA</i> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> has been detected in five individuals (4 kindreds) with CNC who have adrenal tumors and Cushing syndrome (&#x0003c;1% of CNC <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families) [<a class="bk_pop" href="#carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</a>]. In one of these kindreds, the variant was inherited, as both mother and son were carriers; in another individual, the amplification was <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, as neither parent was a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> [<a class="bk_pop" href="#carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</a>].</p></div></dd><dt>9. </dt><dd><div id="carney.TF.1.9"><p class="no_margin">One individual with CNC (&#x0003c;1% of families with CNC) had a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> rearrangement resulting in four copies of <i>PRKACB</i> [<a class="bk_pop" href="#carney.REF.forlino.2014.1065">Forlino et al 2014</a>]. <i>PRKACB</i> encodes the catalytic subunit C&#x003b2; of the cyclic AMP-dependent protein kinase A (PKA). Levels of C&#x003b2; and PKA activity were increased in the individual's lymphoblasts and fibroblasts; the authors propose that this is a CNC-causing <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> variant.</p></div></dd></dl></div></div></div></div></div><div id="carney.Clinical_Characteristics"><h2 id="_carney_Clinical_Characteristics_">Clinical Characteristics</h2><div id="carney.Clinical_Description"><h3>Clinical Description</h3><p>The Carney complex (CNC) of skin pigmentary abnormalities, myxomas, endocrine tumors or overactivity, and schwannomas may be evident at birth, although the median age of diagnosis is 20 years.</p><p><b>Skin pigment abnormalities</b></p><ul><li class="half_rhythm"><div>Pale brown to black lentigines are the most common presenting feature of CNC and may be present at birth. Typically, they increase in number and appear anywhere on the body including the face, the lips, and mucosa around puberty. These lentigines tend to fade after the fourth decade, but may still be evident in the eighth decade.</div></li><li class="half_rhythm"><div>Additional pigmentary abnormalities that develop over time are epithelioid-type blue nevi (small bluish domed papules with a smooth surface), combined nevi, caf&#x000e9; au lait macules, and depigmented lesions.</div></li></ul><p><b>Myxomas</b></p><ul><li class="half_rhythm"><div>Cutaneous myxomas are papules or subcutaneous nodules that usually have a smooth surface and are white, flesh-colored, opalescent, or pink. They appear between birth and the fourth decade. Most individuals with CNC have multiple lesions. Myxomas occur on any part of the body except the hands and feet and typically affect the eyelids, external ear canal, and nipples.</div></li><li class="half_rhythm"><div>Cardiac myxomas occur at a young age and may occur in any or all cardiac chambers. Cardiac myxomas present with symptoms related to intracardiac obstruction of blood flow, embolic phenomenon (into the systemic circulation), and/or heart failure. Myxomas that completely occlude a valvular orifice can cause sudden death.</div></li><li class="half_rhythm"><div>Breast myxomas, often bilateral, occur in females after puberty. Both males and females may develop nipple myxomas at any age.</div></li><li class="half_rhythm"><div>Other sites for myxomas include the oropharynx (tongue, hard palate, pharynx) and the female genital tract (uterus, cervix, vagina).</div></li><li class="half_rhythm"><div>Osteochondromyxoma is a rare myxomatous tumor of the bone that affects nasal sinuses and long bones.</div></li></ul><p><b>Endocrine tumors</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Primary pigmented nodular adrenocortical disease (PPNAD) is associated with adrenocorticotropic hormone (ACTH)-independent overproduction of cortisol (hypercortisolism). PPNAD is the most frequently observed endocrine tumor in individuals with CNC, occurring in an estimated 25% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Among those with a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, Cushing syndrome caused by PPNAD is seen in 70% of affected females before age 45 years but in only 45% of affected males, likely reflecting the generally higher frequency of Cushing syndrome in females. Histologic evidence of PPNAD has been found in almost every individual with CNC undergoing autopsy.</div><div class="half_rhythm">Symptomatic individuals have Cushing syndrome. The hypercortisolism of PPNAD is usually insidious in onset. In children, hypercortisolism is manifest first as weight gain and growth arrest. In adults, long-standing hypercortisolism results in central obesity, "moon facies," hirsutism, striae, hypertension, buffalo hump fat distribution, weakness, easy bruising, and psychological disturbance. In a minority of individuals, PPNAD presents in the first two to three years; in the majority, it presents in the second or third decade.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Growth hormone (GH)-producing adenoma.</b> Clinically evident acromegaly is a relatively frequent manifestation of CNC, occurring in approximately 10% of adults at the time of presentation. Gigantism, resulting from excess GH secretion prior to puberty, is rare. However, asymptomatic increased serum concentration of GH and insulin-like growth factor type-1 (IGF-1), as well as subtle hyperprolactinemia, may be present in up to 75% of individuals with CNC. Somatomammotroph hyperplasia, a putative precursor of GH-producing adenoma, may explain the protracted period of onset of clinical acromegaly in individuals with CNC.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Testicular tumors.</b> Large-cell calcifying Sertoli cell tumors (LCCSCT) are observed in one third of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males at the time of presentation, which is often within the first decade. Most adult males with CNC have evidence of LCCSCT. The tumors are often multicentric and bilateral. LCCSCT is almost always benign; malignancy has been reported only once, in an individual age 62 years. LCCSCT may be hormone producing; gynecomastia in prepubertal and peripubertal boys may result from increased P-450 aromatase expression. Other testicular tumors observed in individuals with LCCSCT include Leydig cell tumors and (pigmented nodular) adrenocortical rest tumors.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Thyroid adenoma or carcinoma.</b> Up to 75% of individuals with CNC have multiple thyroid nodules, most of which are nonfunctioning thyroid follicular adenomas. Thyroid carcinomas, both papillary and follicular, can occur and occasionally may develop in a person with a long history of multiple thyroid adenomas.</div></li></ul><p><b>Psammomatous melanotic schwannoma (PMS).</b> This rare tumor of the nerve sheath occurs in approximately 10% of individuals with CNC. Malignant degeneration occurs in approximately 10% of those with CNC [<a class="bk_pop" href="#carney.REF.watson.2000.413">Watson et al 2000</a>]. PMS may occur anywhere in the central and peripheral nervous system; it is most frequently found in the nerves of the gastrointestinal tract (esophagus and stomach) and paraspinal sympathetic chain (28%). The spinal tumors present as pain and radiculopathy in adults (mean age 32 years).</p><p><b>Breast ductal adenoma</b> is a benign tumor of the mammary gland ducts.</p><p><b>Life span.</b> Most individuals with CNC have a normal life span. However, because some die at an early age, the average life expectancy for individuals with CNC is 50 years. Causes of death include complications of cardiac myxoma (myxoma emboli, cardiomyopathy, cardiac arrhythmia, surgical intervention), metastatic or intracranial PMS, thyroid carcinoma, and metastatic pancreatic and testicular tumors.</p><p><b>Fertility.</b> LCCSCT causes replacement and obstruction of seminiferous tubules, macroorchidism, oligoasthenospermia, and inappropriate hormone production or aromatization. Despite these findings, fertility is frequently preserved.</p></div><div id="carney.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Clinical and genotypic data on more than 380 <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are available from more than 20 years of study at the National Institutes of Health (Bethesda, MD) and the Hospital C&#x000f4;chin (Paris). Phenotype analysis in 353 individuals with 80 different <i>PRKAR1A</i> pathogenic variants is summarized [<a class="bk_pop" href="#carney.REF.bertherat.2009.2085">Bertherat et al 2009</a>]:</p><ul><li class="half_rhythm"><div>A <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was seen more often in individuals with the combination of myxomas (affecting multiple locations; e.g., skin, heart, and breast), psammomatous melanotic schwannomas (PMS), thyroid tumors, and large-cell calcifying Sertoli cell tumors (LCCSCTs) than in individuals with CNC without this combination of findings.</div></li><li class="half_rhythm"><div>The "<a class="def" href="/books/n/gene/glossary/def-item/hot-spot/">hot spot</a>'' <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">c.491_492delTG</a>, was more likely to be associated with lentigines, cardiac myxoma, and thyroid tumors than all other <i>PRKAR1A</i> pathogenic variants combined.</div></li><li class="half_rhythm"><div>Individuals with CNC <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> presented more frequently and earlier in life with pigmented skin lesions, myxomas, thyroid tumors, and gonadal tumors than those without an identifiable pathogenic variant. Tumors that presented at a significantly younger age in <i>PRKAR1A</i> heterozygotes than in individuals with CNC without an identifiable pathogenic variant included cardiac myxomas, thyroid tumors, and LCCSCTs.</div></li><li class="half_rhythm"><div>Those with <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> primary pigmented nodular adrenocortical disease (PPNAD) (which was accompanied by lentiginosis in some individuals) diagnosed before age eight years were rarely <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The two <i>PRKAR1A</i> pathogenic variants commonly seen in those with isolated PPNAD were <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">c.709-7_709-2delATTTTT</a> and <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">c.1A&#x0003e;G</a> substitution affecting the initiation codon of the protein.</div></li><li class="half_rhythm"><div><i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> variants were associated more frequently with lentigines, PMS, acromegaly, and cardiac myxomas than were <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> variants, consistent with the observation that milder phenotypes are more likely to be associated with splice variants than other types of pathogenic variants.</div></li><li class="half_rhythm"><div>Large <i>PRKAR1A</i> deletions (328 bp to 3 Mb) were found to lead to a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that varied but was generally severe and unusual, presumably as a result of <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> of additional genes [<a class="bk_pop" href="#carney.REF.salpea.2014.e183">Salpea et al 2014</a>].</div></li></ul></div><div id="carney.Penetrance"><h3>Penetrance</h3><p>The overall <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of CNC in those with a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is greater than 95% by age 50 years.</p><p>Thus far only two <i>PRKAR1A</i> pathogenic variants are known to result in incomplete <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of CNC: the splice variant <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">c.709-7_709-2del</a> and the initiation-alternating substitution <a class="figpopup" href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object" rid-figpopup="figcarneyTprkar1apathogenicvariantsdis" rid-ob="figobcarneyTprkar1apathogenicvariantsdis">p.Met1Val</a>. When expressed, these two pathogenic variants lead to relatively mild CNC, manifest mostly as PPNAD, which can be accompanied by lentigines [<a class="bk_pop" href="#carney.REF.groussin.2006.1943">Groussin et al 2006</a>].</p></div><div id="carney.Nomenclature"><h3>Nomenclature</h3><p>Carney complex has also been designated by the following acronyms:</p><ul><li class="half_rhythm"><div>NAME (<i>n</i>evi, <i>a</i>trial <i>m</i>yxomas, <i>e</i>phelides)</div></li><li class="half_rhythm"><div>LAMB (<i>l</i>entigines, <i>a</i>trial <i>m</i>yxoma, <i>b</i>lue nevi)</div></li></ul><p><b>"Carney triad"</b> (OMIM <a href="https://omim.org/entry/604287" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604287</a>) is a completely different entity consisting of a triad of gastrointestinal stromal tumors, pulmonary chondroma, and extra-adrenal paraganglioma.</p></div><div id="carney.Prevalence"><h3>Prevalence</h3><p>More than 700 individuals with CNC are known to the authors. These include whites, African Americans, and Asians from North and South America, Europe, Australia, and Asia.</p></div></div><div id="carney.Genetically_Related_Allelic_Disor"><h2 id="_carney_Genetically_Related_Allelic_Disor_">Genetically Related (Allelic) Disorders</h2><p>The following phenotypes are also associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>PRKAR1A</i>:</p><ul><li class="half_rhythm"><div>Sporadic <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> (not CNC-associated) primary pigmented nodular adrenocortical disease (PPNAD) [<a class="bk_pop" href="#carney.REF.groussin.2002.1433">Groussin et al 2002</a>]</div></li><li class="half_rhythm"><div>Sporadic undifferentiated thyroid cancers and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> papillary thyroid cancers [<a class="bk_pop" href="#carney.REF.sandrini.2002b.182">Sandrini et al 2002b</a>]</div></li><li class="half_rhythm"><div>Adrenal tumors [<a class="bk_pop" href="#carney.REF.bertherat.2003.5308">Bertherat et al 2003</a>]</div></li></ul><p>Sporadic tumors (including odontogenic myxomas, occurring as single tumors in the absence of any other findings of this syndrome) have been associated with somatic variants in <i>PRKAR1A</i> that are <b>not</b> present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> [<a class="bk_pop" href="#carney.REF.perdig_o.2005.204">Perdig&#x000e3;o et al 2005</a>]; thus, predisposition to these tumors is not heritable. For more details, see <a href="#carney.Cancer_and_Benign_Tumors">Cancer and Benign Tumors</a>.</p></div><div id="carney.Differential_Diagnosis"><h2 id="_carney_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Skin.</b> Disorders in which lentigines occur include benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> lentiginosis (OMIM <a href="http://omim.org/entry/151001" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">151001</a>), <a href="/books/n/gene/pjs/">Peutz-Jeghers syndrome</a>, <a href="/books/n/gene/leopard/">Noonan syndrome with multiple lentigines</a>, <a href="/books/n/gene/noonan/">Noonan syndrome</a>, and the Bannayan-Riley-Ruvalcaba syndrome, which is one of the phenotypes observed in the <a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndrome</a>. The caf&#x000e9; au lait macules of Carney complex (CNC) can resemble those of <a href="/books/n/gene/mccune-albright/">McCune-Albright syndrome</a>, <a href="/books/n/gene/nf1/">neurofibromatosis 1</a>, <a href="/books/n/gene/nf2/">neurofibromatosis 2</a>, and Watson syndrome (OMIM <a href="http://omim.org/entry/193520" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193520</a>). Epithelioid blue nevi may occur as solitary lesions in individuals who have no findings to suggest CNC.</p><p><b>Cardiac myxoma.</b> Cardiac myxoma is the most common type of cardiac tumor in adults and accounts for approximately 30% of cardiac tumors in children. Genetic studies reveal no apparent association between CNC and <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> myxomas [<a class="bk_pop" href="#carney.REF.fogt.2002.59">Fogt et al 2002</a>].</p><p>Kindreds have been described with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> myxomas, CNC, and cardiomyopathy associated with a single <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of a protein that belongs to the family of myosins [<a class="bk_pop" href="#carney.REF.veugelers.2004.460">Veugelers et al 2004</a>]. This condition is distinct from CNC and is either a separate disorder or the concurrence of two genetic disorders in one family [<a class="bk_pop" href="#carney.REF.stratakis.2004.2556">Stratakis et al 2004</a>].</p><p><b>Endocrine tumors.</b> Thyroid tumors also occur in Cowden syndrome, one of the phenotypes observed in the <a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndrome</a>. Rarely, <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> thyroid tumors may harbor somatic <i>PRKAR1A</i> pathogenic variants [<a class="bk_pop" href="#carney.REF.sandrini.2002b.182">Sandrini et al 2002b</a>].</p><p>Large-cell calcifying Sertoli cell tumor (LCCSCT) is also seen in <a href="/books/n/gene/pjs/">Peutz-Jeghers syndrome</a>, in which the tumor may also be hormone producing. Ovarian tumors similar to those seen in Peutz-Jeghers syndrome are not observed in CNC [<a class="bk_pop" href="#carney.REF.stratakis.2000.4359">Stratakis et al 2000</a>].</p><p>CNC accounts for approximately 80% of bilateral micronodular adrenal hyperplasia; <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> (not CNC-associated) primary pigmented nodular adrenocortical disease (PPNAD) can also be caused by pathogenic variants in <i>PRKAR1A</i> [<a class="bk_pop" href="#carney.REF.groussin.2002.1433">Groussin et al 2002</a>]. Isolated micronodular adrenocortical hyperplasia may be associated with <a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> pathogenic variants in <i>PDE11A</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding dual-specificity phosphodiesterase [<a class="bk_pop" href="#carney.REF.horvath.2006.794">Horvath et al 2006</a>].</p><p>Adrenal cortical tumors are also seen in <a href="/books/n/gene/bws/">Beckwith-Wiedemann syndrome</a>, <a href="/books/n/gene/li-fraumeni/">Li-Fraumeni syndrome</a>, <a href="/books/n/gene/men1/">multiple endocrine neoplasia type 1</a>, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> adrenal hyperplasia resulting from <a href="/books/n/gene/cah/">21-hydroxylase deficiency</a>, and the <a href="/books/n/gene/mccune-albright/">McCune-Albright syndrome</a> [<a class="bk_pop" href="#carney.REF.kjellman.2001.948">Kjellman et al 2001</a>].</p><p>GH-secreting pituitary adenomas (somatotropinomas) can also be seen in <a href="/books/n/gene/men1/">multiple endocrine neoplasia type 1</a> (MEN1) or <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> somatotropinomas (OMIM <a href="https://omim.org/entry/102200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">102200</a>), which map to 11q13.1-q13.3 or 2p16 [<a class="bk_pop" href="#carney.REF.stratakis.2000.4920">Stratakis &#x00026; Kirschner 2000</a>, <a class="bk_pop" href="#carney.REF.frohman.2003.165">Frohman 2003</a>]. Sporadic somatotropinomas or non-CNC- and non-MEN1-associated somatotropinomas do not appear to be frequently associated with <i>PRKAR1A</i> pathogenic variants [<a class="bk_pop" href="#carney.REF.sandrini.2002a.e78">Sandrini et al 2002a</a>, <a class="bk_pop" href="#carney.REF.yamasaki.2003.464">Yamasaki et al 2003</a>].</p><p><b>Schwannomas.</b> CNC is the only genetic condition other than <a href="/books/n/gene/nf1/">neurofibromatosis 1</a>, <a href="/books/n/gene/nf2/">neurofibromatosis 2</a>, and <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <a href="/books/n/gene/schwann/">schwannomatosis</a> in which schwannomas occur.</p></div><div id="carney.Management"><h2 id="_carney_Management_">Management</h2><div id="carney.Evaluations_Following_Initial_Dia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Carney complex (CNC), the following evaluations are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Imaging or biochemical screening for endocrine tumors for diagnostic purposes only</div></li><li class="half_rhythm"><div>Thyroid ultrasonography, recommended as a satisfactory, cost-effective method for determining thyroid involvement in pediatric and young adults with CNC. Its value, however, is questionable in older individuals.</div></li><li class="half_rhythm"><div>In males, testicular ultrasonography at the initial evaluation</div></li><li class="half_rhythm"><div>In females, transabdominal ultrasonography during the first evaluation. Unless an abnormality is detected initially, the test need not be repeated because of the low risk for ovarian malignancy, regardless of age.</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="carney.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>The following interventions are routine:</p><ul><li class="half_rhythm"><div><b>Cardiac myxoma.</b> Open-heart surgery</div></li><li class="half_rhythm"><div><b>Cutaneous and mammary myxoma.</b> Surgical excision</div></li><li class="half_rhythm"><div><b>Cushing syndrome.</b> Bilateral adrenalectomy</div></li><li class="half_rhythm"><div><b>Pituitary adenoma.</b> Transsphenoidal surgery</div></li><li class="half_rhythm"><div><b>Thyroid adenomas.</b> Surgery if cancerous</div></li><li class="half_rhythm"><div><b>LCCSCT.</b> Orchiectomy usually required for boys with aggressively growing LCCSCT and gynecomastia to avoid premature epiphyseal fusion and induction of central precocious puberty. Tumors with lack of growth and mild gynecomastia can be treated medically with aromatase inhibitors.</div></li><li class="half_rhythm"><div><b>PMS.</b> Surgery to remove primary and/or metastatic lesions</div></li></ul></div><div id="carney.Prevention_of_Primary_Manifestati"><h3>Prevention of Primary Manifestations</h3><p>The only preventive measure in an asymptomatic individual is surgical removal of a heart tumor (cardiac myxoma) prior to the development of heart dysfunction, stroke, or other embolism.</p></div><div id="carney.Prevention_of_Secondary_Complicat"><h3>Prevention of Secondary Complications</h3><p>Development of metabolic abnormalities from Cushing syndrome or arthropathy and other complications from acromegaly may be prevented by medical or surgical treatment of the respective endocrine manifestations.</p></div><div id="carney.Surveillance"><h3>Surveillance</h3><p>Recommended clinical surveillance for individuals with CNC and at-risk relatives include the following:</p><p><b>Prepubertal pediatric individuals</b></p><ul><li class="half_rhythm"><div>Echocardiogram (annually; biannually for those with a history of excised myxoma)</div></li><li class="half_rhythm"><div>Testicular ultrasound for boys; close monitoring of growth rate and pubertal staging (annually)</div></li></ul><p><b>Postpubertal pediatric and adult individuals</b></p><ul><li class="half_rhythm"><div>Echocardiogram (annually or biannually for adolescent individuals with a history of excised myxoma)</div></li><li class="half_rhythm"><div>Testicular ultrasound (annually)</div></li><li class="half_rhythm"><div>Thyroid ultrasound (baseline examination; may be repeated as needed)</div></li><li class="half_rhythm"><div>Transabdominal ultrasound of the ovaries (baseline examination; may be repeated as needed)</div></li><li class="half_rhythm"><div>Urinary free cortisol levels (annually)</div></li><li class="half_rhythm"><div>Serum IGF-1 levels (annually)</div></li></ul><p><b>Further evaluation of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of all age groups, as needed</b></p><ul><li class="half_rhythm"><div>For primary pigmented nodular adrenocortical disease, in addition to urinary free cortisol levels:</div><ul><li class="half_rhythm"><div>Diurnal cortisol levels (11:30 pm, 12:00 am and 7:30 am, 8:00 am sampling)</div></li><li class="half_rhythm"><div>Dexamethasone-stimulation test (modified Liddle's test, as per <a class="bk_pop" href="#carney.REF.stratakis.1999.585">Stratakis et al [1999]</a>)</div></li><li class="half_rhythm"><div>Adrenal computed tomography</div></li></ul></li><li class="half_rhythm"><div>For gigantism/acromegaly, in addition to serum IGF-1 levels:</div><ul><li class="half_rhythm"><div>Pituitary MRI</div></li><li class="half_rhythm"><div>Three-hour oral glucose tolerance test (oGTT)</div></li><li class="half_rhythm"><div>90-minute thyroid releasing hormone (TRH) testing</div></li></ul></li><li class="half_rhythm"><div>For psammomatous melanotic schwannoma: MRI (brain, spine, chest, abdomen, retroperitoneum, pelvis)</div></li></ul></div><div id="carney.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures (see <a href="#carney.Evaluations_Following_Initial_Dia">Evaluations Following Initial Diagnosis</a> and <a href="#carney.Surveillance">Surveillance</a>).</p><ul><li class="half_rhythm"><div>If a clinically diagnosed relative has undergone <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and is found to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>PRKAR1A</i>, molecular genetic testing can be used with certainty to clarify the genetic status of at-risk family members.</div></li><li class="half_rhythm"><div>If a clinically diagnosed relative is not available for testing, the use of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for determining the genetic status of at-risk relatives is problematic, and test results need to be interpreted with caution.</div><ul><li class="half_rhythm"><div>Identification of a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an at-risk family member indicates that the same <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> method can be used to assess the genetic status of other at-risk family members.</div></li><li class="half_rhythm"><div>Failure to identify a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in an at-risk family member does not eliminate the possibility that a <i>PRKAR1A</i> pathogenic variant is present; such individuals need to follow the recommendations for clinical surveillance of at-risk family members (see <a href="#carney.Surveillance">Surveillance</a>).</div></li></ul></li></ul><p>See <a href="#carney.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="carney.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="carney.Genetic_Counseling"><h2 id="_carney_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="carney.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Carney complex (CNC) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="carney.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Approximately 70% of individuals diagnosed with CNC have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Approximately 30% of individuals have CNC as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#carney.REF.stelmachowskabanas.2017.3924">Stelmachowska-Banas et al 2017</a>].</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (though theoretically possible, no instances of germline mosaicism have been reported).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with CNC may appear to be negative because of failure to recognize the disorder in family members or early death of the parent before the onset of symptoms. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>In the absence of known family history, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with CNC has a 50% chance of inheriting the <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Fertility may be impaired in males with CNC.</div></li><li class="half_rhythm"><div>It is possible that pregnancies in which a <i>PRKAR1A</i>-<a class="def" href="/books/n/gene/glossary/def-item/inactivating/">inactivating</a> variant is present are more likely to end in spontaneous abortion; however, no data are yet available.</div></li></ul><p><b>Other family members.</b> The risk to the other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>PRKAR1A</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="carney.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Testing at-risk asymptomatic adults and children.</b> It is appropriate to consider <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of young at-risk family members in order to guide medical management (see Management, <a href="#carney.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a>).</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="carney.Prenatal_Testing_and_Preimplantat"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <a href="/gene/5573" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>PRKAR1A</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p><p><b>Fetal ultrasound examination.</b> A fetal heart tumor detected prenatally by ultrasound examination in an at-risk fetus may suggest the diagnosis; however, absence of such prenatal ultrasound findings does not rule out the diagnosis.</p></div></div><div id="carney.Resources"><h2 id="_carney_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Carney%20complex&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Carney complex</a></div></li><li class="half_rhythm"><div><b>American Cancer Society (ACS)</b></div><div>250 Williams Street Northwest</div><div>Atlanta GA 30303</div><div><b>Phone:</b> 800-227-2345 (toll-free 24/7); 866-228-4327 (toll-free 24/7 TTY)</div><div><a href="http://www.cancer.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancer.org</a></div></li><li class="half_rhythm"><div><b>American Heart Association (AHA)</b></div><div>7272 Greenville Avenue</div><div>Dallas TX 75231</div><div><b>Phone:</b> 800-242-8721 (toll-free)</div><div><b>Email:</b> review.personal.info@heart.org</div><div><a href="http://www.americanheart.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.americanheart.org</a></div></li><li class="half_rhythm"><div><b>CancerNetwork.com</b></div><div><a href="http://www.cancernetwork.com" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancernetwork.com</a></div></li><li class="half_rhythm"><div><b>National Cancer Institute (NCI)</b></div><div>6116 Executive Boulevard</div><div>Suite 300</div><div>Bethesda MD 20892-8322</div><div><b>Phone:</b> 800-422-6237 (toll-free)</div><div><b>Email:</b> cancergovstaff@mail.nih.gov</div><div><a href="http://www.cancer.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancer.gov</a></div></li></ul></div><div id="carney.Molecular_Genetics"><h2 id="_carney_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="carney.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Carney Complex: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1286/table/carney.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carney.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_carney.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_carney.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_carney.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_carney.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_carney.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_carney.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_carney.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5573" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>PRKAR1A</i></a></td><td headers="hd_b_carney.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5573" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">17q24<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_b_carney.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P10644" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">cAMP-dependent protein kinase type I-alpha regulatory subunit</a></td><td headers="hd_b_carney.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/PRKAR1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKAR1A database</a><br /><a href="https://prkar1a.nichd.nih.gov/hmdb/mutations.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKAR1A Mutation Database</a></td><td headers="hd_b_carney.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRKAR1A" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKAR1A</a></td><td headers="hd_b_carney.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=PRKAR1A[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PRKAR1A</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="carney.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="carney.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Carney Complex (<a href="/omim/160980,188830,605244" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1286/table/carney.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carney.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/160980" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">160980</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARNEY COMPLEX, TYPE 1; CNC1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/188830" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">188830</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">PROTEIN KINASE, cAMP-DEPENDENT, REGULATORY, TYPE I, ALPHA; PRKAR1A</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/605244" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">605244</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CARNEY COMPLEX, TYPE 2; CNC2</td></tr></tbody></table></div></div><div id="carney.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p><b>Gene structure.</b>
<i>PRKAR1A</i> has a <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> length of approximately 21 kb. The longest transcript variant <a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=47132582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_212472.1</a> is composed of 11 exons; codon 1 is noncoding. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1286/#carney.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> A total of 125 different <i>PRKAR1A</i> pathogenic variants have been identified (see <a href="http://prkar1a.nichd.nih.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><i>PRKAR1A</i> Mutation Database</a>) in 401 unrelated families of diverse ethnic origin [<a class="bk_pop" href="#carney.REF.horvath.2010.369">Horvath et al 2010</a>].</p><p>Missense, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, frameshift, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants as well as several relatively large deletions have been reported [<a class="bk_pop" href="#carney.REF.horvath.2008.388">Horvath et al 2008</a>, <a class="bk_pop" href="#carney.REF.salpea.2014.e183">Salpea et al 2014</a>]. Most variants are <a class="def" href="/books/n/gene/glossary/def-item/private/">private</a> [<a class="bk_pop" href="#carney.REF.bertherat.2009.2085">Bertherat et al 2009</a>]. To date, only three pathogenic variants have been found in more than three unrelated pedigrees: c.82C&#x0003e;T (p.Gln28Ter), c.491_492delTG, and c.709-7_709-2delATTTTT; these pathogenic variants occurred in kindreds with different racial and ethnic backgrounds, suggesting that they arose independently. The c.491_492delTG and c.709-7_709-2delATTTTT pathogenic variants were confirmed to be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> and likely represent "hot spots'' [<a class="bk_pop" href="#carney.REF.kirschner.2000.89">Kirschner et al 2000</a>, <a class="bk_pop" href="#carney.REF.groussin.2006.1943">Groussin et al 2006</a>].</p><p>A relatively small proportion of pathogenic variants result in the expression of an altered protein, including one splice variant that leads to an <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> change (c.177+3A&#x0003e;G).</p><div id="carney.T.prkar1a_pathogenic_variants_dis" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>PRKAR1A</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1286/table/carney.T.prkar1a_pathogenic_variants_dis/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carney.T.prkar1a_pathogenic_variants_dis_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference<br />Sequences</th></tr></thead><tbody><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1A&#x0003e;G&#x000a0;<sup>2</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1Val</td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_3" rowspan="8" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/entrez/viewer.fcgi?db=nuccore&#x00026;id=47132582" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_212472<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/entrez/viewer.fcgi?db=protein&#x00026;id=47132583" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_997637<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.82C&#x0003e;T&#x000a0;<sup>2</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gln28Ter</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.177+3A&#x0003e;G</td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.491_492delTG&#x000a0;<sup>2</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val164ArgfsTer5</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.709-7_709-2delATTTTT&#x000a0;<sup>3</sup><br />(c.709(-7-2)del6)</td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 1 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr><tr><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Exon 9-11 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_carney.T.prkar1a_pathogenic_variants_dis_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">--</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="carney.TF.2.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="carney.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#carney.REF.kirschner.2000.89">Kirschner et al [2000]</a></p></div></dd><dt>3. </dt><dd><div id="carney.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#carney.REF.groussin.2006.1943">Groussin et al [2006]</a></p></div></dd><dt>4. </dt><dd><div id="carney.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#carney.REF.salpea.2014.e183">Salpea et al [2014]</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The PRKAR1A protein consists of 381 amino acid residues organized in a dimerization/docking <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> at the amino terminus, followed by a PKA inhibitor site, two tandem binding domains for cAMP at the carboxyl terminus (cAMP:A and cAMP:B), and a linker region that contains the main docking site for the C subunit [<a class="bk_pop" href="#carney.REF.zawadzki.2004.7029">Zawadzki &#x00026; Taylor 2004</a>]. <i>PRKAR1A</i> is a tumor suppressor gene.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Haploinsufficiency of PRKAR1A causes CNC. In tumors of individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with CNC, <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> inactivation of <i>PRKAR1A</i> leads to enhanced intracellular signaling by protein kinase A (PKA), as evidenced by an almost twofold greater response to cAMP in CNC tumors than in non-CNC tumors [<a class="bk_pop" href="#carney.REF.groussin.2002.1433">Groussin et al 2002</a>].</p><div id="carney.Cancer_and_Benign_Tumors"><h4>Cancer and Benign Tumors</h4><p><i>PRKACA</i> somatic pathogenic variants have been detected in 37% of unilateral adenomas from individuals with overt Cushing's syndrome [<a class="bk_pop" href="#carney.REF.beuschlein.2014.1019">Beuschlein et al 2014</a>].</p></div></div></div><div id="carney.References"><h2 id="_carney_References_">References</h2><div id="carney.Published_Guidelines__Consensus_S"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="carney.REF1">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <a href="http://ascopubs.org/doi/full/10.1200/JCO.2009.27.0660" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2010. Accessed 10-30-18.</div></li></ul></div><div id="carney.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="carney.REF.bertherat.2003.5308">Bertherat J, Groussin L, Sandrini F, Matyakhina L, Bei T, Stergiopoulos S, Papageorgiou T, Bourdeau I, Kirschner LS, Vincent-Dejean C, Perlemoine K, Gicquel C, Bertagna X, Stratakis CA. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:5308–19.</span> [<a href="/pubmed/14500362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14500362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.bertherat.2009.2085">Bertherat J, Horvath A, Groussin L, Grabar S, Boikos S, Cazabat L, Libe R, Ren&#x000e9;-Corail F, Stergiopoulos S, Bourdeau I, Bei T, Clauser E, Calender A, Kirschner LS, Bertagna X, Carney JA, Stratakis CA. Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:2085–91.</span> [<a href="/pmc/articles/PMC2690418/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2690418</span></a>] [<a href="/pubmed/19293268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19293268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.beuschlein.2014.1019">Beuschlein F, Fassnacht M, Assi&#x000e9; G, Calebiro D, Stratakis CA, Osswald A, Ronchi CL, Wieland T, Sbiera S, Faucz FR, Schaak K, Schmittfull A, Schwarzmayr T, Barreau O, Vezzosi D, Rizk-Rabin M, Zabel U, Szarek E, Salpea P, Forlino A, Vetro A, Zuffardi O, Kisker C, Diener S, Meitinger T, Lohse MJ, Reincke M, Bertherat J, Strom TM, Allolio B. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">370</span>:1019–28.</span> [<a href="/pmc/articles/PMC4727447/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4727447</span></a>] [<a href="/pubmed/24571724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24571724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.cazabat.2007.1">Cazabat L, Lib&#x000e8; R, Perlemoine K, Ren&#x000e9;-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J, Raffin-Sanson ML. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. <span><span class="ref-journal">Eur J Endocrinol. </span>2007;<span class="ref-vol">157</span>:1–8.</span> [<a href="/pubmed/17609395" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17609395</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.fogt.2002.59">Fogt F, Zimmerman RL, Hartmann CJ, Brown CA, Narula N. Genetic alterations of Carney complex are not present in sporadic cardiac myxomas. <span><span class="ref-journal">Int J Mol Med. </span>2002;<span class="ref-vol">9</span>:59–60.</span> [<a href="/pubmed/11744997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11744997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.forlino.2014.1065">Forlino A, Vetro A, Garavelli L, Ciccone R, London E, Stratakis CA, Zuffardi O.N. PRKACB and Carney complex. <span><span class="ref-journal">N Engl J Med. </span>2014;<span class="ref-vol">370</span>:1065–7.</span> [<a href="/pubmed/24571725" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24571725</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.frohman.2003.165">Frohman LA. Isolated familial somatotropinomas: clinical and genetic considerations. <span><span class="ref-journal">Trans Am Clin Climatol Assoc. </span>2003;<span class="ref-vol">114</span>:165–77.</span> [<a href="/pmc/articles/PMC2194520/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2194520</span></a>] [<a href="/pubmed/12813918" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12813918</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.groussin.2006.1943">Groussin L, Horvath A, Jullian E, Boikos S, Rene-Corail F, Lefebvre H, Cephise-Velayoudom FL, Vantyghem MC, Chanson P, Conte-Devolx B, Lucas M, Gentil A, Malchoff CD, Tissier F, Carney JA, Bertagna X, Stratakis CA, Bertherat J. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2006;<span class="ref-vol">91</span>:1943–9.</span> [<a href="/pubmed/16464939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16464939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.groussin.2002.1433">Groussin L, Kirschner LS, Vincent-Dejean C, Perlemoine K, Jullian E, Delemer B, Zacharieva S, Pignatelli D, Carney JA, Luton JP, Bertagna X, Stratakis CA, Bertherat J. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD. <span><span class="ref-journal">Am J Hum Genet. </span>2002;<span class="ref-vol">71</span>:1433–42.</span> [<a href="/pmc/articles/PMC378588/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC378588</span></a>] [<a href="/pubmed/12424709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12424709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.horvath.2010.369">Horvath A, Bertherat J, Groussin L, Guillaud-Bataille M, Tsang K, Cazabat L, Lib&#x000e9; R, Remmers E, Ren&#x000e9;-Corail F, Faucz FR, Clauser E, Calender A, Bertagna X, Carney JA, Stratakis CA. Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase A (PRKAR1A): an update. <span><span class="ref-journal">Hum Mutat. </span>2010;<span class="ref-vol">31</span>:369–79.</span> [<a href="/pmc/articles/PMC2936101/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2936101</span></a>] [<a href="/pubmed/20358582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20358582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.horvath.2006.794">Horvath A, Boikos S, Giatzakis C, Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E, Delimpasi G, Hsiao HP, Keil M, Heyerdahl S, Matyakhina L, Libe R, Fratticci A, Kirschner LS, Cramer K, Gaillard RC, Bertagna X, Carney JA, Bertherat J, Bossis I, Stratakis CA. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:794–800.</span> [<a href="/pubmed/16767104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16767104</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.horvath.2008.388">Horvath A, Bossis I, Giatzakis C, Levine E, Weinberg F, Meoli E, Robinson-White A, Siegel J, Soni P, Groussin L, Matyakhina L, Verma S, Remmers E, Nesterova M, Carney JA, Bertherat J, Stratakis CA. Large deletions of the PRKAR1A gene in Carney complex. <span><span class="ref-journal">Clin Cancer Res. </span>2008;<span class="ref-vol">14</span>:388–95.</span> [<a href="/pubmed/18223213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18223213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.kirschner.2000.89">Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS, Stratakis CA. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:89–92.</span> [<a href="/pubmed/10973256" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973256</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.kjellman.2001.948">Kjellman M, Larsson C, Backdahl M. Genetic background of adrenocortical tumor development. <span><span class="ref-journal">World J Surg. </span>2001;<span class="ref-vol">25</span>:948–56.</span> [<a href="/pubmed/11572037" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11572037</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.mateus.2008.801">Mateus C, Palangi&#x000e9; A, Franck N, Groussin L, Bertagna X, Avril MF, Bertherat J, Dupin N. Heterogeneity of skin manifestations in patients with Carney complex. <span><span class="ref-journal">J Am Acad Dermatol. </span>2008;<span class="ref-vol">59</span>:801–10.</span> [<a href="/pubmed/18804312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18804312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.perdig_o.2005.204">Perdig&#x000e3;o PF, Stergiopoulos SG, De Marco L, Matyakhina L, Boikos SA, Gomez RS, Pimenta FJ, Stratakis CA. Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2005;<span class="ref-vol">44</span>:204–11.</span> [<a href="/pubmed/16001434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16001434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.salpea.2014.e183">Salpea P, Horvath A, London E, Faucz FR, Vetro A, Levy I, Gourgari E, Dauber A, Holm IA, Morrison PJ, Keil MF, Lyssikatos C, Smith ED, Sanidad MA, Kelly JC, Dai Z, Mowrey P, Forlino A, Zuffardi O, Stratakis CA. Deletions of the PRKAR1A locus at 17q24.2-q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2014;<span class="ref-vol">99</span>:E183–8.</span> [<a href="/pmc/articles/PMC3879675/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3879675</span></a>] [<a href="/pubmed/24170103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24170103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.sandrini.2002a.e78">Sandrini F, Kirschner LS, Bei T, Farmakidis C, Yasufuku-Takano J, Takano K, Prezant TR, Marx SJ, Farrell WE, Clayton RN, Groussin L, Bertherat J, Stratakis CA. PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex. <span><span class="ref-journal">J Med Genet. </span>2002a;<span class="ref-vol">39</span>:e78.</span> [<a href="/pmc/articles/PMC1757227/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757227</span></a>] [<a href="/pubmed/12471216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.sandrini.2002b.182">Sandrini F, Matyakhina L, Sarlis NJ, Kirschner LS, Farmakidis C, Gimm O, Stratakis CA. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer. <span><span class="ref-journal">Genes Chromosomes Cancer. </span>2002b;<span class="ref-vol">35</span>:182–92.</span> [<a href="/pubmed/12203783" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12203783</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stelmachowskabanas.2017.3924">Stelmachowska-Banas M, Zgliczynski W, Tutka P, Carney JA, Korbonits M. Fatal Carney complex in siblings due to de novo large gene deletion. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2017;<span class="ref-vol">102</span>:3924–7.</span> [<a href="/pmc/articles/PMC5673275/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5673275</span></a>] [<a href="/pubmed/28973408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28973408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stratakis.2004.2556">Stratakis CA, Bertherat J, Carney JA. Mutation of perinatal myosin heavy chain. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">351</span>:2556–8.</span> [<a href="/pubmed/15590965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15590965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stratakis.1996.699">Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. <span><span class="ref-journal">J Clin Invest. </span>1996;<span class="ref-vol">97</span>:699–705.</span> [<a href="/pmc/articles/PMC507106/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC507106</span></a>] [<a href="/pubmed/8609225" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8609225</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stratakis.2000.4920">Stratakis CA, Kirschner LS. Isolated familial somatotropinomas: does the disease map to 11q13 or to 2p16? <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2000;<span class="ref-vol">85</span>:4920–1.</span> [<a href="/pubmed/11134164" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11134164</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stratakis.2000.4359">Stratakis CA, Papageorgiou T, Premkumar A, Pack S, Kirschner LS, Taymans SE, Zhuang Z, Oelkers WH, Carney JA. Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2000;<span class="ref-vol">85</span>:4359–66.</span> [<a href="/pubmed/11095480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11095480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.stratakis.1999.585">Stratakis CA, Sarlis N, Kirschner LS, Carney JA, Doppman JL, Nieman LK, Chrousos GP, Papanicolaou DA. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. <span><span class="ref-journal">Ann Intern Med. </span>1999;<span class="ref-vol">131</span>:585–91.</span> [<a href="/pubmed/10523219" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10523219</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.veugelers.2004.460">Veugelers M, Bressan M, McDermott DA, Weremowicz S, Morton CC, Mabry CC, Lefaivre JF, Zunamon A, Destree A, Chaudron JM, Basson CT. Mutation of perinatal myosin heavy chain associated with a Carney complex variant. <span><span class="ref-journal">N Engl J Med. </span>2004;<span class="ref-vol">351</span>:460–9.</span> [<a href="/pubmed/15282353" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15282353</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.watson.2000.413">Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, Carney JA, Oldfield EH. Neurosurgical implications of Carney complex. <span><span class="ref-journal">J Neurosurg. </span>2000;<span class="ref-vol">92</span>:413–8.</span> [<a href="/pubmed/10701527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10701527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.yamasaki.2003.464">Yamasaki H, Mizusawa N, Nagahiro S, Yamada S, Sano T, Itakura M, Yoshimoto K. GH-secreting pituitary adenomas infrequently contain inactivating mutations of PRKAR1A and LOH of 17q23-24. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2003;<span class="ref-vol">58</span>:464–70.</span> [<a href="/pubmed/12641630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12641630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carney.REF.zawadzki.2004.7029">Zawadzki KM, Taylor SS. cAMP-dependent protein kinase regulatory subunit type IIbeta: active site mutations define an isoform-specific network for allosteric signaling by cAMP. <span><span class="ref-journal">J Biol Chem. </span>2004;<span class="ref-vol">279</span>:7029–36.</span> [<a href="/pubmed/14625280" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14625280</span></a>]</div></li></ul></div></div><div id="carney.Chapter_Notes"><h2 id="_carney_Chapter_Notes_">Chapter Notes</h2><div id="carney.Author_Notes"><h3>Author Notes</h3><p><a href="https://science.nichd.nih.gov/confluence/display/segen/Home" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Section on Endocrinology and Genetics</a></p></div><div id="carney.Author_History"><h3>Author History</h3><p>Anelia Horvath, PhD; National Institutes of Health (2003-2015)<br />Margarita Raygada, MSc, PhD (2015-present)<br />Paraskevi Salpea, PhD; National Institutes of Health (2015-2018)<br />Constantine A Stratakis, MD, DSc (2003-present)</p></div><div id="carney.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>16 August 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 January 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>20 September 2012 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 June 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 January 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 March 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>5 February 2003 (me) Review posted live</div></li><li class="half_rhythm"><div>7 October 2002 (cs) Original submission</div></li></ul><p>Note: Pursuant to 17 USC Section 105 of the United States Copyright Act, the <i>GeneReview</i> "Carney Complex" is in the public <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> in the United States of America.</p></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1286</span><span class="label">PMID: <a href="/pubmed/20301463" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301463</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cfc/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cpt1a/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1286&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1286/?report=reader">PubReader</a></li><li><a href="/books/NBK1286/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1286" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1286" style="display:none" title="Cite this Page"><div class="bk_tt">Stratakis CA, Raygada M. Carney Complex. 2003 Feb 5 [Updated 2018 Aug 16]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1286/pdf/Bookshelf_NBK1286.pdf">PDF version of this page</a> (464K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#carney.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#carney.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#carney.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#carney.Genetically_Related_Allelic_Disor" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#carney.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#carney.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#carney.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#carney.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#carney.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#carney.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#carney.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5573[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PRKAR1A</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1286+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1467226" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1467226" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1467226" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1467226" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23315333" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation.</a><span class="source">[Insights Imaging. 2013]</span><div class="brieflinkpop offscreen_noflow">The complex of myxomas, spotty skin pigmentation and endocrine overactivity (Carney complex): imaging findings with clinical and pathological correlation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Courcoutsakis NA, Tatsi C, Patronas NJ, Lee CC, Prassopoulos PK, Stratakis CA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Insights Imaging. 2013 Feb; 4(1):119-33. Epub 2013 Jan 12.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16756677" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carney complex (CNC).</a><span class="source">[Orphanet J Rare Dis. 2006]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Carney complex (CNC).<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bertherat J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2006 Jun 6; 1:21. Epub 2006 Jun 6.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301710" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Multiple Endocrine Neoplasia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Multiple Endocrine Neoplasia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Giusti F, Marini F, Brandi ML. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21536508" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Carney complex].</a><span class="source">[Endocrinol Nutr. 2011]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> [Carney complex].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Losada Grande EJ, Al Kassam Martínez D, González Boillos M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Endocrinol Nutr. 2011 Jun-Jul; 58(6):308-14. Epub 2011 May 4.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28871709" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.</a><span class="source">[Neuro Endocrinol Lett. 2017]</span><div class="brieflinkpop offscreen_noflow">Unusual presentations of Carney Complex in patient with a novel PRKAR1A mutation.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Akin S, Noyan S, Dagdelen S, Pasaoglu I, Kaynaroglu V, Askun MM, Bilen CY, Kiratli H, Baydar DE, Onder S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Neuro Endocrinol Lett. 2017 Aug; 38(4):248-254. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301463" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301463" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04193275f66d18aa92240e">Carney Complex - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Carney Complex - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:21:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8AD524E040D10100000000054B020D&amp;ncbi_session=CE8AD524E0419321_1355SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1286%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1286&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1286/&amp;ncbi_pagename=Carney Complex - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8AD524E0419321_1355SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>